As summarized in Figure 5, the CD19-CAR T cells significantly inhibited the tumor growth upon application of the CD19-4D5scFv fusion protein, compared to the CD19-CAR T cells without the fusion protein or in the presence of the CD19-his protein for the control. This evidence concerns the gene CD19 and neoplasm.